BOYDSense is developing a non-invasive health monitoring platform, starting with Diabetes. Our device named Lassie, like the dog of the series in the 80s, measures volatile organic compound (VOCs) biomarkers in exhaled breath. Lassie will make it easier and painless for people with diabetes to monitor their blood glucose all through the day by simply breathing. The device will be affordable, gentle and non-invasive. Our latest performance data from interim data analysis are showing scientifically proven results. Our mission is to democratize health-monitoring devices to improve people life.
Location: France, Occitania, Toulouse
Employees: 1-10
Total raised: $2.8M
Founded date: 2015
Investors 2
| Date | Name | Website |
| 08.05.2024 | Serpentine... | serpentine... |
| 13.04.2024 | Swiss Diab... | diabetesfu... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 05.01.2022 | Grant | $2.8M | - |
Mentions in press and media 1
| Date | Title | Description |
| 02.10.2020 | Sweet Ventures invests in BOYDSense to bring non-invasive glucose monitoring using breath analysis to people with diabetes | Toulouse (France) and Vienna (Austria), October 2nd, 2020. |